Skip to main content
Clinical Trials/CTRI/2023/08/056963
CTRI/2023/08/056963
Not yet recruiting
Phase 3

Randomised controlled clinical trial to compare the efficacy of dhatryadi kwath and vasadi kwath in management of vatarakta. - Nil

Vd Ravindra Namdev Sagbhor0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vd Ravindra Namdev Sagbhor
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Vd Ravindra Namdev Sagbhor

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran.
  • Patient of any sex, religion and socio\-economic status.
  • 2\.newly diagnosed patient.
  • 3\.Patient with serum uric acid \>7mg/dl in male and 6mg/dl in female.

Exclusion Criteria

  • 1\.Pathophysiology or genetic syndrome associated with vatarakta.
  • 2\.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded.
  • 3 malignancy, poorly controlled DM,HTN.
  • 4\.symptomatic patient with clinical evidence of heart failure.
  • 5\.complicated patient having target organ damage.
  • 6\.alcoholic and drug abusers, pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials